| Optimizing lonafarnib treatment for the management of chronic delta hepatitis: the LOWR HDV‐1 study C Yurdaydin, O Keskin, Ç Kalkan, F Karakaya, A Çalişkan, E Karatayli, ... Hepatology 67 (4), 1224-1236, 2018 | 159 | 2018 |
| Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection G Bozdayi, AR Türkyilmaz, R Idilman, E Karatayli, S Rota, C Yurdaydin, ... Journal of medical virology 76 (4), 476-481, 2005 | 111 | 2005 |
| Interferon treatment duration in patients with chronic delta hepatitis and its effect on the natural course of the disease C Yurdaydin, O Keskin, Ç Kalkan, F Karakaya, A Çalişkan, G Kabaçam, ... The Journal of infectious diseases 217 (8), 1184-1192, 2018 | 106 | 2018 |
| A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment E Karatayli, S Karayalçin, H Karaaslan, H Kayhan, AR Türkyilmaz, ... Antiviral therapy 12 (5), 761-768, 2007 | 64 | 2007 |
| Entecavir treatment of chronic hepatitis D G Kabaçam, FO Önder, M Yakut, G Seven, SC Karatayli, E Karatayli, ... Clinical infectious diseases 55 (5), 645-650, 2012 | 63 | 2012 |
| A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis C Yurdaydin, O Keskin, E Yurdcu, A Çalişkan, S Önem, F Karakaya, ... Hepatology 75 (6), 1551-1565, 2022 | 58 | 2022 |
| QTLs for pre-and postweaning body weight and body composition in selected mice GA Brockmann, E Karatayli, CS Haley, U Renne, OJ Rottmann, S Karle Mammalian genome 15, 593-609, 2004 | 44 | 2004 |
| A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control E Karataylı, YÇ Altunoğlu, SC Karataylı, SGK Alagöz, K Çınar, K Yalçın, ... Journal of clinical virology 60 (1), 11-15, 2014 | 42 | 2014 |
| O118: Optimizing the prenylation inhibitor lonafarnib using ritonavir boosting in patients with chronic delta hepatitis C Yurdaydin, R Idilman, I Choong, C Kalkan, O Keskin, MF Karakaya, ... Journal of Hepatology, S252, 2015 | 36 | 2015 |
| Antimicrobial and antiviral screening of novel indole carboxamide and propanamide derivatives S Ölgen, N Altanlar, E Karataylı, M Bozdayı Zeitschrift für Naturforschung C 63 (3-4), 189-195, 2008 | 35 | 2008 |
| Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency GK Alagoz, SC Karatayli, E Karatayli, E Çelik, O Keskin, B Dinç, K Cinar, ... Turk J Gastroenterol 25 (4), 405-410, 2014 | 34 | 2014 |
| Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients İ Çelik, E Karataylı, E Çevik, S Gökçe Kabakçı, SC Karataylı, B Dinç, ... Archives of virology 156, 2215-2220, 2011 | 32 | 2011 |
| Tumour necrosis factor‐alpha, interleukin‐10, interferon‐gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta SC Karatayli, ZE Ulger, AA Ergul, O Keskin, E Karatayli, R Albayrak, ... Journal of viral hepatitis 21 (4), 297-304, 2014 | 30 | 2014 |
| Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury E Karatayli, RA Hall, SN Weber, S Dooley, F Lammert Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (2), 298-307, 2019 | 29 | 2019 |
| Association of the PTPN22 gene polymorphism with autoantibody positivity in Turkish rheumatoid arthritis patients A Ates, Y Karaaslan, E Karatayli, E Ertuğrul, S Aksaray, A Türkyilmaz, ... Tissue Antigens 78 (1), 56-59, 2011 | 28 | 2011 |
| Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection E Karatayli, SC Karatayli, K Cinar, S Gokahmetoglu, K Güven, R Idilman, ... Journal of clinical virology 53 (2), 130-134, 2012 | 27 | 2012 |
| Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B O Keskin, AÇ Örmeci, B Baran, G Kabaçam, A Tüzün, E Karatayli, F Akyüz, ... Antiviral therapy 19 (6), 543-550, 2014 | 25 | 2014 |
| Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2. 15 cell lines H Kayhan, E Karatayli, AR Turkyilmaz, F Sahin, C Yurdaydin, AM Bozdayi Archives of virology 152, 871-879, 2007 | 25 | 2007 |
| Investigation of West Nile virus among healthy blood donors in the western part of Turkey SU Biçeroğlu, E Karatayli, A Bayram, A Turhan, A Değirmenci, Y Aydinok, ... Turkish Journal of Medical Sciences 45 (1), 84-88, 2015 | 24 | 2015 |
| Interleukin‐28 gene polymorphisms may contribute to HB sAg persistence and the development of HB eAg‐negative chronic hepatitis B SC Karataylı, M Bozdayı, E Karataylı, T Öztürk, AA Husseini, R Albayrak, ... Liver International 35 (3), 846-853, 2015 | 23 | 2015 |
